{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:25:32Z","timestamp":1790753132134,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1245\/s10434-023-14276-8","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T19:04:15Z","timestamp":1696878255000},"page":"8528-8541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Need for Centralization for Small Intestinal Neuroendocrine Tumor Surgery: A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET Study"],"prefix":"10.1245","volume":"30","author":[{"given":"Maroin","family":"Kalifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Deguelte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Faron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Afchain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"de Mestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Pasquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Subtil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Poncet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"issue":"5","key":"14276_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.dld.2020.02.011","volume":"52","author":"L de Mestier","year":"2020","unstructured":"de Mestier L, Lepage C, Baudin E, et al. Digestive Neuroendocrine Neoplasms (NEN): French Intergroup clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, GTE, RENATEN, TENPATH, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis. 2020;52(5):473\u201392. https:\/\/doi.org\/10.1016\/j.dld.2020.02.011.","journal-title":"Dig Liver Dis."},{"issue":"7","key":"14276_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.6004\/jnccn.2021.0032","volume":"19","author":"MH Shah","year":"2021","unstructured":"Shah MH, Goldner WS, Benson AB, et al. Neuroendocrine and adrenal tumors, Version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(7):839\u201368. https:\/\/doi.org\/10.6004\/jnccn.2021.0032.","journal-title":"J Natl Compr Canc Netw."},{"issue":"11","key":"14276_CR3","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1245\/s10434-018-6676-2","volume":"25","author":"KJ Keck","year":"2018","unstructured":"Keck KJ, Maxwell JE, Utria AF, et al. The distal predilection of small bowel neuroendocrine tumors. Ann Surg Oncol. 2018;25(11):3207\u201313. https:\/\/doi.org\/10.1245\/s10434-018-6676-2.","journal-title":"Ann Surg Oncol."},{"issue":"21","key":"14276_CR4","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.3390\/cancers13215473","volume":"13","author":"A Pasquer","year":"2021","unstructured":"Pasquer A, Walter T, Milot L, Hervieu V, Poncet G. Principles of surgical management of small intestinal NET. Cancers. 2021;13(21):5473. https:\/\/doi.org\/10.3390\/cancers13215473.","journal-title":"Cancers."},{"issue":"7","key":"14276_CR5","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00268-013-1918-8","volume":"37","author":"CS Landry","year":"2013","unstructured":"Landry CS, Lin HY, Phan A, et al. Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors. World J Surg. 2013;37(7):1695\u2013700. https:\/\/doi.org\/10.1007\/s00268-013-1918-8.","journal-title":"World J Surg."},{"issue":"1","key":"14276_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11605-017-3524-9","volume":"22","author":"BM Motz","year":"2018","unstructured":"Motz BM, Lorimer PD, Boselli D, Hill JS, Salo JC. Optimal lymphadenectomy in small bowel neuroendocrine tumors: analysis of the NCDB. J Gastrointest Surg. 2018;22(1):117\u201323. https:\/\/doi.org\/10.1007\/s11605-017-3524-9.","journal-title":"J Gastrointest Surg."},{"issue":"5","key":"14276_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1159\/000441423","volume":"103","author":"S Lardi\u00e8re-Deguelte","year":"2016","unstructured":"Lardi\u00e8re-Deguelte S, de Mestier L, App\u00e9r\u00e9 F, et al. Toward a preoperative classification of lymph node metastases in patients with small intestinal neuroendocrine tumors in the era of intestinal-sparing surgery. Neuroendocrinology. 2016;103(5):552\u20139. https:\/\/doi.org\/10.1159\/000441423.","journal-title":"Neuroendocrinology."},{"issue":"S5","key":"14276_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1245\/s10434-016-5574-8","volume":"23","author":"A Pasquer","year":"2016","unstructured":"Pasquer A, Walter T, Rousset P, et al. Lymphadenectomy during small bowel neuroendocrine tumor surgery: the concept of skip metastases. Ann Surg Oncol. 2016;23(S5):804\u20138. https:\/\/doi.org\/10.1245\/s10434-016-5574-8.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"14276_CR9","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1245\/s10434-018-6511-9","volume":"25","author":"L Chen","year":"2018","unstructured":"Chen L, Song Y, Zhang Y, Chen M, Chen J. Exploration of the exact prognostic significance of lymphatic metastasis in jejunoileal neuroendocrine tumors. Ann Surg Oncol. 2018;25(7):2067\u201374. https:\/\/doi.org\/10.1245\/s10434-018-6511-9.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"14276_CR10","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s11605-022-05359-0","volume":"26","author":"P Wang","year":"2022","unstructured":"Wang P, Chen E, Xie M, et al. The number of lymph nodes examined is associated with survival outcomes of neuroendocrine tumors of the jejunum and ileum (siNET): development and validation of a prognostic model based on SEER database. J Gastrointest Surg. 2022;26(9):1917\u201329. https:\/\/doi.org\/10.1007\/s11605-022-05359-0.","journal-title":"J Gastrointest Surg."},{"issue":"6","key":"14276_CR11","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","volume":"46","author":"JR Howe","year":"2017","unstructured":"Howe JR, Cardona K, Fraker DL, et al. The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017;46(6):715\u201331. https:\/\/doi.org\/10.1097\/MPA.0000000000000846.","journal-title":"Pancreas."},{"issue":"Suppl 3","key":"14276_CR12","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1245\/s10434-015-4620-2","volume":"22","author":"A Pasquer","year":"2015","unstructured":"Pasquer A, Walter T, Hervieu V, et al. Surgical management of small bowel neuroendocrine tumors: specific requirements and their impact on staging and prognosis. Ann Surg Oncol. 2015;22(Suppl 3):742\u20139. https:\/\/doi.org\/10.1245\/s10434-015-4620-2.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"14276_CR13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/SLA.0000000000002965","volume":"268","author":"R Vonlanthen","year":"2018","unstructured":"Vonlanthen R, Lodge P, Barkun JS, et al. Toward a consensus on centralization in surgery. Ann Surg. 2018;268(5):712\u201324. https:\/\/doi.org\/10.1097\/SLA.0000000000002965.","journal-title":"Ann Surg."},{"issue":"5","key":"14276_CR14","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/SLA.0000000000002898","volume":"268","author":"M El Amrani","year":"2018","unstructured":"El Amrani M, Clement G, Lenne X, et al. The impact of hospital volume and charlson score on postoperative mortality of proctectomy for rectal cancer: a nationwide study of 45,569 patients. Ann Surg. 2018;268(5):854\u201360. https:\/\/doi.org\/10.1097\/SLA.0000000000002898.","journal-title":"Ann Surg."},{"issue":"8","key":"14276_CR15","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/bjs.9468","volume":"101","author":"GA Gooiker","year":"2014","unstructured":"Gooiker GA, Lemmens VEPP, Besselink MG, et al. Impact of centralization of pancreatic cancer surgery on resection rates and survival. Br J Surg. 2014;101(8):1000\u20135. https:\/\/doi.org\/10.1002\/bjs.9468.","journal-title":"Br J Surg."},{"issue":"5","key":"14276_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/SLA.0000000000001768","volume":"264","author":"A Pasquer","year":"2016","unstructured":"Pasquer A, Renaud F, Hec F, et al. Is centralization needed for esophageal and gastric cancer patients with low operative risk? A nationwide study. Ann Surg. 2016;264(5):823\u201330. https:\/\/doi.org\/10.1097\/SLA.0000000000001768.","journal-title":"Ann Surg."},{"issue":"13","key":"14276_CR17","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/bjs.10931","volume":"105","author":"M van Putten","year":"2018","unstructured":"van Putten M, Nelen SD, Lemmens VEPP, et al. Overall survival before and after centralization of gastric cancer surgery in the Netherlands. Br J Surg. 2018;105(13):1807\u201315. https:\/\/doi.org\/10.1002\/bjs.10931.","journal-title":"Br J Surg."},{"issue":"5","key":"14276_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/SLA.0000000000004326","volume":"272","author":"B Noiret","year":"2020","unstructured":"Noiret B, Clement G, Lenne X, et al. Centralization and oncologic training reduce postoperative morbidity and failure-to-rescue rates after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: study on a 10-year National French Practice. Ann Surg. 2020;272(5):847\u201354. https:\/\/doi.org\/10.1097\/SLA.0000000000004326.","journal-title":"Ann Surg."},{"issue":"8","key":"14276_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/jso.25727","volume":"120","author":"Y Kasai","year":"2019","unstructured":"Kasai Y, Mahuron K, Hirose K, et al. Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors. J Surg Oncol. 2019;120(8):1311\u20137. https:\/\/doi.org\/10.1002\/jso.25727.","journal-title":"J Surg Oncol."},{"issue":"2","key":"14276_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/bjc.2012.560","volume":"108","author":"G Yadegarfar","year":"2013","unstructured":"on behalf of the EORTC Quality of Life Group, Yadegarfar G, Friend L, et al. Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours. Br J Cancer. 2013;108(2):301\u201310. https:\/\/doi.org\/10.1038\/bjc.2012.560.","journal-title":"Br J Cancer."},{"key":"14276_CR21","unstructured":"Fayers PM, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 Scoring Manual: This Manual Is Intended to Assist Users with Scoring Procedures for the QLQ-C30 Version 3 and Earlier, and the QLQ Supplementary Modules. 3rd ed. EORTC; 2001."},{"issue":"6","key":"14276_CR22","doi-asserted-by":"publisher","first-page":"e220097","DOI":"10.1530\/EC-22-0097","volume":"11","author":"C Morin","year":"2022","unstructured":"Morin C, Benedetto KM, Deville A, et al. Management of neuroendocrine neoplasms: conformity with guidelines in and outside a center of excellence. Endocr Connect. 2022;11(6):e220097. https:\/\/doi.org\/10.1530\/EC-22-0097.","journal-title":"Endocr Connect."},{"issue":"3","key":"14276_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","volume":"105","author":"A Sundin","year":"2017","unstructured":"Sundin A, Arnold R, Baudin E, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine and hybrid imaging. Neuroendocrinology. 2017;105(3):212\u201344. https:\/\/doi.org\/10.1159\/000471879.","journal-title":"Neuroendocrinology."},{"issue":"8","key":"14276_CR24","doi-asserted-by":"publisher","first-page":"e13008","DOI":"10.1111\/jne.13008","volume":"33","author":"E Ka\u00e7maz","year":"2021","unstructured":"Ka\u00e7maz E, Chen JW, Tanis PJ, Nieveen van Dijkum EJM, Engelsman AF. Postoperative morbidity and mortality after surgical resection of small bowel neuroendocrine neoplasms: a systematic review and meta-analysis. J Neuroendocrinol. 2021;33(8):e13008. https:\/\/doi.org\/10.1111\/jne.13008.","journal-title":"J Neuroendocrinol."},{"issue":"11","key":"14276_CR25","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/bjs.11716","volume":"107","author":"G Balzano","year":"2020","unstructured":"Balzano G, Guarneri G, Pecorelli N, et al. Modelling centralization of pancreatic surgery in a nationwide analysis. Br J Surg. 2020;107(11):1510\u20139. https:\/\/doi.org\/10.1002\/bjs.11716.","journal-title":"Br J Surg."},{"issue":"5","key":"14276_CR26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/SLA.0000000000003532","volume":"270","author":"M El Amrani","year":"2019","unstructured":"El Amrani M, Lenne X, Clement G, et al. Specificity of procedure volume and its association with postoperative mortality in digestive cancer surgery: a nationwide study of 225,752 patients. Ann Surg. 2019;270(5):775\u201382. https:\/\/doi.org\/10.1097\/SLA.0000000000003532.","journal-title":"Ann Surg."},{"issue":"7","key":"14276_CR27","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.hpb.2019.10.2443","volume":"22","author":"M Elamrani","year":"2020","unstructured":"Elamrani M, Cl\u00e9ment G, Lenne X, et al. Should all pancreatic surgery be centralized regardless of patients\u2019 comorbidity? HPB. 2020;22(7):1057\u201366. https:\/\/doi.org\/10.1016\/j.hpb.2019.10.2443.","journal-title":"HPB."},{"issue":"4","key":"14276_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1097\/SLA.0000000000001437","volume":"263","author":"T Hata","year":"2016","unstructured":"Hata T, Motoi F, Ishida M, et al. Effect of hospital volume on surgical outcomes after pancreaticoduodenectomy: a systematic review and meta-analysis. Ann Surg. 2016;263(4):664\u201372. https:\/\/doi.org\/10.1097\/SLA.0000000000001437.","journal-title":"Ann Surg."},{"issue":"5","key":"14276_CR29","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/SLA.0000000000002399","volume":"266","author":"O Farges","year":"2017","unstructured":"Farges O, Bendersky N, Truant S, Delpero JR, Pruvot FR, Sauvanet A. The theory and practice of pancreatic surgery in France. Ann Surg. 2017;266(5):797\u2013804. https:\/\/doi.org\/10.1097\/SLA.0000000000002399.","journal-title":"Ann Surg."},{"issue":"6","key":"14276_CR30","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/01.sla.0000188462.00249.36","volume":"242","author":"NT van Heek","year":"2005","unstructured":"van Heek NT, Kuhlmann KFD, Scholten RJ, et al. Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in The Netherlands. Ann Surg. 2005;242(6):781\u201390. https:\/\/doi.org\/10.1097\/01.sla.0000188462.00249.36.","journal-title":"Ann Surg."},{"issue":"4","key":"14276_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/ans.13112","volume":"86","author":"D O\u2019Kane","year":"2016","unstructured":"O\u2019Kane D, Papa N, Lawrentschuk N, Syme R, Giles G, Bolton D. Supervisor volume affects oncological outcomes of trainees performing open radical prostatectomy: oncological outcomes by surgeon volume. ANZ J Surg. 2016;86(4):249\u201354. https:\/\/doi.org\/10.1111\/ans.13112.","journal-title":"ANZ J Surg."},{"issue":"2","key":"14276_CR32","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.injury.2015.01.023","volume":"46","author":"AC Gray","year":"2015","unstructured":"Gray AC, Fearon PV, Gregory R. Major trauma centres and trauma networks\u2014the potential impact on surgical training. Injury. 2015;46(2):176\u20137. https:\/\/doi.org\/10.1016\/j.injury.2015.01.023.","journal-title":"Injury"},{"issue":"10","key":"14276_CR33","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.dld.2011.04.021","volume":"43","author":"C Le Roux","year":"2011","unstructured":"Le Roux C, Lombard-Bohas C, Delmas C, et al. Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study. Dig Liver Dis. 2011;43(10):828\u201333. https:\/\/doi.org\/10.1016\/j.dld.2011.04.021.","journal-title":"Dig Liver Dis."},{"issue":"1","key":"14276_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000371807","volume":"101","author":"MK Kim","year":"2015","unstructured":"Kim MK, Warner RRP, Ward SC, et al. Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Neuroendocrinology. 2015;101(1):58\u201365. https:\/\/doi.org\/10.1159\/000371807.","journal-title":"Neuroendocrinology."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14276-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-14276-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14276-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T15:16:43Z","timestamp":1699197403000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-14276-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":34,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["14276"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-14276-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"24 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Louis de Mestier has received consulting and congress fees from AAA\/Novartis, Ipsen, Viatris; consulting and research fees from Esteve; and consulting fees from Mayoly and SIRTex. Thierry Lecomte has received personal fees from IPSEN, Keocyte and AAA, outside the submitted work. Thomas Walter has received fees from Novartis, Ipsen, Keocyt, and Terumo. Maroin Kalifi, Sophie Deguelte, Matthieu Faron, Pauline Afchain, Arnaud Pasquer, Fabien Subtil, Khalid Alghamdi, and Gilles Poncet have no disclosures to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}